论文部分内容阅读
美国FDA于2011年5月2日批准Tradjenta片剂(有效成分为linagliptin)治疗成人2型糖尿病,主要用于结合饮食和运动改善病人对血糖水平的控制。胰岛素是一种调节血糖水平的激素,而2型糖尿病患者主要是由于自身不能产生胰岛素或者对胰岛素无正
US FDA approved Tradjenta tablet (active ingredient linagliptin) on May 2, 2011 to treat type 2 diabetes in adults and is used primarily to improve the patient’s control of blood glucose levels in conjunction with diet and exercise. Insulin is a hormone that regulates blood sugar levels, whereas patients with type 2 diabetes are predominantly unable to produce insulin or have no positive effect on insulin